Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
SEBI has proposed to widen the participation of Foreign Portfolio Investors (FPIs) in commodity derivatives markets while ensuring strict safeguards for delivery obligations. This move is aimed at enhancing liquidity and market depth.
SEBI has amended the ILMDS Regulations concerning face value of municipal debt, escrow mechanisms, and reporting timelines, effective immediately. These changes streamline the regulatory framework governing municipal securities.
The Bombay High Court has quashed bifurcation and deemed conveyance orders due to violations of natural justice and non-compliance with the Maharashtra Cooperative Societies Act.
The Delhi High Court has requested the Institute of Company Secretaries of India (ICSI) to clarify its authority to define 26 areas of practice, including those pertaining to law, amid concerns over professional jurisdiction.
The NCLT has approved a resolution plan incorporating amalgamation and capital restructuring for SAB Events, subject to statutory compliance. This highlights the NCLT's flexibility in resolving financial challenges for MSMEs.
The NCLT held that objections raised by the Registrar of Companies (RoC) cannot halt the dissolution of a company after it has complied with voluntary liquidation provisions. This decision clarifies the authority of procedural compliance in corporate dissolution.
The Supreme Court has affirmed that appeals lodged with the High Court before the amendment of Section 15Z of the SEBI Act continue to be maintainable, thereby dismissing a contrary appeal.
SEBI has introduced a risk-based framework for market intermediary inspections for the fiscal year 2026-27, allowing joint inspections and reducing the frequency of inspections. This aims to optimize resource allocation and strengthen regulatory oversight.
In the case of Novartis AG v. Venkata Narayana Active Ingredients, the Madras High Court has provided clarity on the evidentiary requirements for invoking the Bolar exemption, marking a notable development in pharmaceutical patent law.
The Bombay High Court has upheld the Directorate General of Foreign Trade's (DGFT) ban on sugar exports, despite significant financial losses to exporters. The court emphasized that its decisions are based on legal principles rather than anticipated outcomes.
InterGlobe Enterprises and Accor have received unconditional approval for their merger from the CCI. JSA Advocates facilitated the merger control process, advising the parties involved throughout.
The ITAT upholds the fair market value as the cost of acquisition under Section 49(2AA) for NRIs calculating capital gains on ESOPs, providing significant relief for foreign investors.